✦ LIBER ✦

Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer

✍ Scribed by Massimo Maffezzini; Alberto Bossi; Laurence Collette

Book ID: 113609696
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 328 KB
Volume: 51
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2006.10.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The fall and rise of prostate-specific a

The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

✍ Gunar K. Zagars; Alan Pollack 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 890 KB

Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O

Time to Prostate-Specific Antigen Nadir

Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality

✍ Christine S. Chung; Ming-Hui Chen; Jennifer Cullen; David McLeod; Peter Carroll; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Re: Systematic Review of Pretreatment Pr

Re: Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time as Predictors for Prostate Cancer

✍ George N. Thalmann 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 107 KB

How to compare results after surgery or

How to compare results after surgery or radiation for localized prostate carcinoma : Prostate specific antigen (PSA) outcome (No), posttreatment PSA doubling time (Maybe), or survival (Yes)?

✍ Anthony V. D'Amico 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

In addressing the clinically relevant question regarding prostate specific antigen (PSA) outcome data in the study presented by Vicini and colleagues in this issue of __Cancer__, the author concurs with Vicini et al. that only a randomized trial powered to assess survival ultimately can answer the i

Influence of body mass index on prostate

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

✍ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio

UP-2.128: The Value of Prostate-Specific

UP-2.128: The Value of Prostate-Specific Antigen Doubling Time for Patients with Prostate Cancer After Maximal Androgen Blockade

✍ W. Wang; G. Shi; J. He; R. Zhou 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB